Protection by D609 through cell-cycle regulation after stroke

Molecular Neurobiology

Volumn 41, Issue 2-3, 2010, Pages 206-217

  Adibhatla, Rao Muralikrishna ^a,b,c   Hatcher, James F ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Cardiovascular Research Center   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Cdk inhibitors; Cell cycle inhibition; Ceramide; CNS injury; Focal cerebral ischemia; HIF 1 ; Inflammation; Lipid peroxidation; P21; PC PLC; Phosphatidic acid; PRb; Sphingomyelin synthase; Stroke

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CERAMIDE; E1B PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; P21 ACTIVATED KINASE; PHOSPHATIDYLCHOLINE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; SOMATOMEDIN C; SPHINGOMYELIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; ANTIOXIDANT; BIOLOGICAL MARKER; BRIDGED COMPOUND; CELL CYCLE PROTEIN; THIOKETONE; TRICYCLODECANE-9-YL-XANTHOGENATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTE; BRAIN INFARCTION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL MATURATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; MACROPHAGE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REPERFUSION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; UPREGULATION; ANIMAL; BRAIN ISCHEMIA; CELL CYCLE; CEREBRAL ARTERY DISEASE; DRUG EFFECTS; HUMAN; LIPID METABOLISM; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; BRIDGED COMPOUNDS; CELL CYCLE; CELL CYCLE PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID METABOLISM; MALE; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STROKE; THIONES;

EID: 77955089770     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12035-010-8100-1     Document Type: Conference Paper

References (83)

1. Rashidian J, Iyirhiaro GO, Park DS (2007) Cell cycle machinery and stroke. Biochim Biophys Acta 1772(4):484-493
2. Wang W, Bu B, Xie M, Zhang M, Yu Z, Tao D (2009) Neural cell cycle dysregulation and central nervous system diseases. Prog Neurobiol 89(1):1-17
3. Herrup K, Neve R, Ackerman SL, Copani A (2004) Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 24 (42):9232-9239
4. Osuga H, Osuga S, Wang F, Fetni R, Hogan MJ, Slack RS, Hakim AM, Ikeda J-E, Park DS (2000) Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci 97(18):10254-10259
5. Cerbon J, del Carmen Lopez-Sanchez R (2003) Diacylglycerol generated during sphingomyelin synthesis is involved in protein kinase C activation and cell proliferation in Madin-Darby canine kidney cells. Biochem J 373(Pt 3):917-924
6. Luberto C, Hannun YA (1998) SM synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does SM synthase account for the putative PC-specific PLC? J Biol Chem 273(23):14550-14559
7. Amtmann E (1996) The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholi-pase C. Drugs Exp Clin Res 22(6):287-294
8. Sultana R, Newman SF, Abdul HM, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA (2006) Protective effect of D609 against amyloid-β 1-42 induced oxidative modification of neuronal proteins: redox proteomics study. J Neurosci Res 84(2):409-417
9. Zhou DH, Lauderback CM, Yu T, Brown SA, Butterfield DA, Thompson JS (2001) D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. J Pharmacol Exp Ther 298(1):103-109
10. Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, Butterfield DA (2006) In vivo protection by the xanthate tricyclodecan-9-yl- xanthogenate against amyloid β-peptide (1-42)-induced oxidative stress. Neuroscience 138(4):1161-1170
11. Bai A, Meier GP, Wang Y, Luberto C, Hannun YA, Zhou D (2004) Prodrug modification increases potassium tricyclo [5.2.1.02, 6]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells. J Pharmacol Exp Ther 309(3):1051-1059
12. Chen C, Hu Q, Yan J, Lei J, Qin L, Shi X, Luan L, Yang L, Wang K, Han J, Nanda A, Zhou C (2007) Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1α and apoptotic genes in a middle cerebral artery occlusion induced focal ischemia rat model. J Neurochem 102(6):1831-1841
13. Monick MM, Carter AB, Gudmundsson G, Mallampalli RK, Powers LS, Hunninghake GW (1999) A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide- stimulated human alveolar macrophages. J Immunol 162(5):3005-3012
14. Zhang F, Zhao G, Dong Z (2001) Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide. Intl Immunopharmacol 1(7):1375-1384
15. Machleidt T, Kramer B, Adam D, Neumann B, Schutze S, Wiegmann K, Kronke M (1996) Function of the p55 TNF receptor "death domain" mediated by phosphatidylcholine-specific PLC. J Exp Med 184(2):725-733
16. Li YH, Maher P, Schubert D (1998) Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc Natl Acad Sci 95(13):7748-7753
17. Singh ATK, Radeff JM, Kunnel JG, Stern PH (2000) Phosphatidylcholine- specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim Biophys Acta 1487(2-3):201-208
18. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M (1994) Functional dichotomy of neutral and acidic sphingomyelinases in TNF-a signaling. Cell 78(6):1005-1015
19. 2. Mol Cells 26(5):481-485
20. Riboni L, Viani P, Bassi R, Giussani P, Tettamanti G (2001) Basic fibroblast growth factor-induced proliferation of primary astrocytes. Evidence for the involvement of sphingomyelin biosynthesis. J Biol Chem 276(16):12797-12804
21. Huitema K, van den Dikkenberg J, Brouwers JFHM, Holthuis JCM (2004) Identification of a family of animal sphingomyelin synthases. EMBO J 23(1):33-44
22. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4(8):604-616
23. 2-induced cell-cycle arrest. Proc Natl Acad Sci 97(17):9498-9503
24. Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression. J Biol Chem 277(34):31263-31269
25. Lee JY, Bielawska AE, Obeid LM (2000) Regulation of cyclin-dependent kinase 2 activity by ceramide. Exp Cell Res 261 (2):303-311
26. Arnold HK, Sears RC (2006) Protein phosphatase 2A regulatory subunit B56a associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol 26(7):2832-2844
27. Huwiler A, Pfeilschifter J (2006) Hypoxia and lipid signaling. Biol Chem 387(10/11):1321-1328
28. Sharp FR, Bernaudin M (2004) HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5(6):437-448
29. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC (2007) Neuron-specific inactivation of the hypoxia inducible factor 1a increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27(23):6320-6332
30. Chavez JC, LaManna JC (2002) Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 22 (20):8922-8931
31. Aragones J, Jones DR, Martin S, Juan MAS, Alfranca A, Vidal F, Vara A, Merida I, Landazuri MO (2001) Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension. J Biol Chem 276(13):10548-10555
32. Temes E, Martin-Puig S, Aragones J, Jones DR, Olmos G, Merida I, Landazuri MO (2004) Role of diacylglycerol induced by hypoxia in the regulation of HIF-1a activity. Biochem Biophys Res Commun 315(1):44-50
33. Teo ST, Yung YC, Herr DR, Chun J (2009) Lysophosphatidic acid in vascular development and Disease. IUBMB Life 61(8):791-799
34. Correia SC, Moreira PI (2009) Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration? J Neurochem 112(1):1-12
35. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, Johnson RS, Lipton SA, Barlow C (2005) Brain-specific knock-out of hypoxia-inducible factor-1α reduces rather than increases hypoxic-ischemic damage. J Neurosci 25(16):4099-4107
36. Piret J-P, Mottet D, Raes M, Michiels C (2002) Is HIF-1α a pro-or an anti-apoptotic protein? Biochem Pharmacol 64(5-6):889-892
37. Guo S, Miyake M, Liu KJ, Shi H (2009) Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment. J Neurochem 108(5):1309-1321
38. 2 and CTP-phosphocholine cytidylyltransferase after stroke. J Biol Chem 281 (10):6718-6725
39. Dogan A, Baskaya MK, Rao AM, Dempsey RJ (1998) Intra-luminal suture occlusion of the middle cerebral artery in spontaneously hypertensive rats. Neurol Res 20(3):265-270
40. 2 is induced in reactive glia following different forms of neuro-degeneration. Glia 27(2):110-128
41. Adibhatla RM, Hatcher JF, Tureyen K (2005) CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke. Brain Res 1058(1-2):193-197
42. 2 IIA is up-regulated by TNF-α and IL-1α/ß after transient focal cerebral ischemia in rat. Brain Res 1134(1):199-205
43. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10(2):290-293
44. Adibhatla RM, Hatcher JF, Dempsey RJ (2001) Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke 32(10):2376-2381
45. Adibhatla RM, Hatcher JF, Dempsey RJ (2004) Cytidine-5′- diphosphocholine (CDP-choline) affects CTP:phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia. J Neurosci Res 76(3):390-396
46. Qin J, Goswami R, Balabanov R, Dawson G (2007) Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J Neurosci Res 85(5):977-984
47. Gao S, Zhang RL, Greenberg ME, Sun M, Chen X, Levison BS, Salomon RG, Hazen SL (2006) Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo. J Biol Chem 281(42):31298-31308
48. Adibhatla RM, Hatcher JF (2010) Lipid oxidation and peroxida-tion in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antiox Redox Signal 12(1):125-169
49. Yu ZF, Nikolova-Karakashian M, Zhou DH, Cheng GJ, Schuchman EH, Mattson MP (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 15(2):85-97
50. Kubota M, Narita K, Nakagomi T, Tamura A, Shimasaki H, Ueta N, Yoshida S (1996) Sphingomyelin changes in rat cerebral cortex during focal ischemia. Neurol Res 18(4):337-341
51. Perry RJ, Ridgway ND (2004) The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609. J Lipid Res 45(1):164-173
52. Chou W-H, Messing RO (2005) Protein kinase C isozymes in stroke. Trends Cardiovasc Med 15(2):47-51
53. Monick MM, Mallampalli RK, Carter AB, Flaherty DM, McCoy D, Robeff PK, Peterson MW, Hunninghake GW (2001) Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages. J Immunol 167 (10):5977-5985
54. Walker JL, Assoian RK (2005) Integrin-dependent signal trans-duction regulating cyclin D1 expression and G1 phase cell cycle progression. Cancer Metastasis Rev 24(3):383-393
55. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellu-lar localization. Genes Dev 12(22):3499-3511
56. Luberto C, Kraveka JM, Hannun YA (2002) Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology. Neurochem Res 27(7/8):609-617
57. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K (1995) PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14(9):1961-1969
58. Pettus BJ, Chalfant CE, Hannun YA (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585 (2-3):114-125
59. Goodman Y, Mattson MP (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta peptide toxicity. J Neurochem 66(2):869-872
60. Shinpo K, Kikuchi S, Moriwaka F, Tashiro K (1999) Protective effects of the TNF-ceramide pathway against glutamate neurotox-icity on cultured mesencephalic neurons. Brain Res 819(1-2): 170-173
61. Ito A, Horigome K (1995) Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J Neurochem 65(1):463-466
62. Furuya K, Ginis I, Takeda H, Chen Y, Hallenbeck JM (2001) Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab 21(3):226-232
63. Siddiqui RA, Jenski LJ, Harvey KA, Wiesehan JD, Stillwell W, Zaloga GP (2003) Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem J 371(2):621-629
64. kip in nasopharyngeal carcinoma cells. Cancer Lett 193(2):149-154
65. 2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40(3):376-387
66. Adibhatla RM, Hatcher JF (2008) Altered lipid metabolism in brain injury and disorders. In: Quinn PJ, Wang X (eds) Lipids in health and disease, vol.49. Springer, New York, pp 241-268
67. Kadl A, Bochkov VN, Huber J, Leitinger N (2004) Apoptotic cells as sources for biologically active oxidized phospholipids. Antiox Redox Signal 6(2):311-320
68. Bratton DL, Henson PM (2005) Autoimmunity and apoptosis: refusing to go quietly. Nat Med 11(1):26-27
69. Chang M-K, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, Witztum JL (2004) Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflamma-tory. J Exp Med 200(11):1359-1370
70. Zhang Q, Chen C, Lu J, Xie M, Pan D, Luo X, Yu Z, Dong Q, Wang W (2009) Cell cycle inhibition attenuates microglial proliferation and production of IL-1beta, MIP-1alpha, and NO after focal cerebral ischemia in the rat. Glia 57(8):908-920
71. Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5(8):629-640
72. Adibhatla RM, Hatcher JF (2008) Integration of cytokine biology and lipid metabolism in stroke. Front Biosci 13(1):1250-1270
73. Wang N, Lv X, Su L, Zhao B, Zhang S, Miao J (2006) D609 blocks cell survival and induces apoptosis in neural stem cells. Bioorg Med Chem Lett 16(18):4780-4783
74. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B (2005) A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25(1):119-135
75. waf1/cip1 in cell cycle-independent neuroprotection. J Neurosci 28(1):163-176
76. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS (2003) Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia. Mol Cell Biol 23(1):359-369
77. Ng MNP, Kitos TE, Cornell RB (2004) Contribution of lipid second messengers to the regulation of phosphatidylcholine synthesis during cell cycle re-entry. Biochim Biophys Acta 1686 (1-2):85-99
78. Larsen EC, Hatcher JF, Adibhatla RM (2007) Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells. Neuroscience 146(3):946-961
79. Antony P, Farooqui AA, Horrocks LA, Freysz L (2001) Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol. FEBS Lett 509 (1):115-118
80. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27(10):2596-2605
81. Madinier A, Bertrand N, Mossiat C, Prigent-Tessier A, Beley A, Marie C, Garnier P (2009) Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS ONE 4(12):e8101
82. Monk PN, Shaw PJ (2006) ALS: life and death in a bad neighborhood. Nat Med 12(8):885-887
83. Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: The dual role of microglia. Neuroscience 158 (3):1021-1029